SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,909,000 | +18.3% | 19,976 | +2.8% | 0.02% | +13.6% |
| Q2 2020 | $3,303,000 | +55.3% | 19,436 | +5.4% | 0.02% | +29.4% |
| Q1 2020 | $2,127,000 | +5.3% | 18,438 | +4.3% | 0.02% | +21.4% |
| Q4 2019 | $2,020,000 | +62.4% | 17,677 | +21.4% | 0.01% | +40.0% |
| Q3 2019 | $1,244,000 | +27.3% | 14,565 | +3.1% | 0.01% | +25.0% |
| Q2 2019 | $977,000 | -5.1% | 14,122 | +0.4% | 0.01% | -11.1% |
| Q1 2019 | $1,030,000 | -18.5% | 14,069 | -37.0% | 0.01% | +50.0% |
| Q4 2018 | $1,264,000 | +310.4% | 22,316 | +177.5% | 0.01% | +50.0% |
| Q2 2014 | $308,000 | -2.2% | 8,042 | +16.2% | 0.00% | -20.0% |
| Q1 2014 | $315,000 | +11.7% | 6,918 | -2.0% | 0.01% | 0.0% |
| Q4 2013 | $282,000 | +5.6% | 7,060 | +16.0% | 0.01% | 0.0% |
| Q3 2013 | $267,000 | – | 6,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |